The EHA2026 Congress is the 31st Annual Congress of the European Hematology Association (EHA), bringing together hematologists, oncologists, researchers, scientists, nurses, pharmacists, and healthcare professionals from around the world. The congress focuses on the latest advances in hematology, including blood cancers, benign blood disorders, diagnostics, genomics, cellular therapies, stem cell transplantation, translational research, and emerging treatment approaches. The event provides a platform for scientific exchange, education, collaboration, and discussion of cutting-edge developments shaping the future of hematology care.